Rémy Gébleux

Rémy Gébleux began their career in 2010 as a Co-op Student at GSK. In 2012, they took on the role of Associate I at Novartis, where they evaluated enzymatic lysis with methionine γ-lyase for the purpose of Methionine labeling and optimized the crystallization process for proteins of interest. In 2013, they worked as an Intern at Philochem AG before taking on the role of PhD Student at ETH Zurich. Finally, in 2016, they became a Senior Scientist at NBE-Therapeutics AG.

Rémy Gébleux completed their PhD in Pharmaceutical Sciences from ETH Zürich between 2013 and 2016. Prior to that, they obtained a Diplome d'ingenieur chimiste and a Master of research in Biology from Ecole Nationale Supérieure de Chimie de Montpellier between 2008 and 2012, with a field of study in Chemistry and Biology.